Abstract
We demonstrate that activation of nuclear factor κB (NF-κB) in neurons is neuroprotective in response to kainic acid (KA)-induced excitotoxicity. Combination of Western blotting, immunocytochemistry, and electrophoresis mobility shift assay showed that KA exposure induced a fast but transient nuclear translocation of the NF-κB p65 subunit and increased DNA-binding activity of NF-κB in primary cultured cortical neurons. The transient NF-κB activity was associated with upregulation of antiapoptotic Bcl-xL and XIAP gene products revealed by real-time PCR. Knockdown of p65 decreased neuronal viability and antiapoptotic gene expression. In addition, we showed that KA-stimulated DNA-binding activity of NF-κB was associated with reactive oxygen species and calcium signals, using AMPA/KA receptor antagonist, calcium chelator, and antioxidant. These results suggest that the fast and transient activation of NF-κB initiated by calcium signals is one of the important proximal events in response to KA-induced excitotoxicity, which has neuroprotective effect against KA-induced apoptosis.
Similar content being viewed by others
Abbreviations
- AMPA:
-
α-aminomethylisoxazole-propionic acid
- CTZ:
-
cyclothiazide
- DTT:
-
dithiothreitol
- EMSA:
-
electrophoretic mobility shift assay
- KA:
-
kainic acid
- MTT:
-
3(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide
- NF-κB:
-
nuclear factor κB
- PMSF:
-
phenylmethylsulfonyl fluoride
- RNAi:
-
RNA interference
- ROS:
-
reactive oxygen species
References
Choi, D. W. (1988) Neuron, 1, 623–634.
Farooqui, A. A., Yi Ong, W., Lu, X. R., Halliwell, B., and Horrocks, L. A. (2001) Brain Res. Rev., 38, 61–78.
Sen, R., and Baltimore, D. (1986) Cell, 47, 921–928.
Hayden, M. S., and Ghosh, S. (2004) Genes Dev., 18, 2195–2224.
Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. (2002) Nat. Rev. Cancer, 2, 301–310.
Karin, M., and Greten, F. R. (2005) Nat. Rev. Immunol., 5, 749–759.
Huang, T. T., Kudo, N., Yoshida, M., and Miyamoto, S. (2000) Proc. Natl. Acad. Sci. USA, 97, 1014–1019.
Johnson, C., van Antwerp, D., and Hope, T. J. (1999) EMBO J., 18, 6682–6693.
Gloire, G., Legrand-Poels, S., and Piette, J. (2006) Biochem. Pharmacol., 72, 1493–1505.
Devary, Y., Rosette, C., DiDonato, J. A., and Karin, M. (1993) Science, 261, 1442–1445.
Schoonbroodt, S., and Piette, J. (2000) Biochem. Pharmacol., 60, 1075–1083.
Mattson, M. P., Culmsee, C., Yu, Z., and Camandola, S. (2000) J. Neurochem., 74, 443–456.
Mattson, M. P., and Camandola, S. (2001) J. Clin. Invest., 107, 247–254.
Coyle, J. T., and Puttfarcken, P. (1993) Science, 262, 689–695.
Fridmacher, V., Kaltschmidt, B., Goudeau, B., Ndiaye, D., Rossi, F. M., Pfeiffer, J., Kaltschmidt, C., Israel, A., and Memet, S. (2003) J. Neurosci., 23, 9403–9408.
Wang, C. H., Chang, A., Tsai, M. J., Cheng, H., Liao, L. P., and Lin, A. M. (2005) Ann. N. Y. Acad. Sci., 1042, 314–324.
Lubin, F. D., Johnston, L. D., Sweatt, J. D., and Anderson, A. E. (2005) Neuroscience, 133, 969–981.
Blondeau, N., Widmann, C., Lazdunski, M., and Heurteaux, C. (2001) J. Neurosci., 21, 4668–4677.
Bhakar, A. L., Tannis, L. L., Zeindler, C., Russo, M. P., Jobin, C., Park, D. S., MacPherson, S., and Barker, P. A. (2002) J. Neurosci., 22, 8466–8475.
Won, S. J., Ko, H. W., Kim, E. Y., Park, E. C., Huh, K., Jung, N. P., Choi, I., Oh, Y. K., Shin, H. C., and Gwag, B. J. (1999) Neuroscience, 94, 83–91.
Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., and Schwaninger, M. (1999) Nat. Med., 5, 554–559.
Nakai, M., Qin, Z. H., Chen, J. F., Wang, Y., and Chase, T. N. (2000) J. Neurochem., 74, 647–658.
Jia, Y. H., Zhu, X., Li, S. Y., Ni, J. H., and Jia, H. T. (2006) Neurosci. Lett., 403, 103–108.
Li, S. Y., Ni, J. H., Xu, D. S., and Jia, H. T. (2003) Neurosci. Lett., 352, 105–108.
Zhang, H. Y., Gu, Y. Y., Li, Z. G., Jia, Y. H., Yuan, L., Li, S. Y., An, G. S., Ni, J. H., and Jia, H. T. (2004) Neoplasia, 6, 802–812.
Chen, Y. L., Law, P. Y., and Loh, H. H. (2006) J. Biol. Chem., 281, 3067–3074.
Carriedo, S. G., Sensi, S. L., Yin, H. Z., and Weiss, J. H. (2000) J. Neurosci., 20, 240–250.
Guerrini, L., Blasi, F., and Denis-Donini, S. (1995) Proc. Natl. Acad. Sci. USA, 92, 9077–9081.
Simpson, C. S., and Morris, B. J. (1999) J. Neurochem., 73, 353–361.
Wellmann, H., Kaltschmidt, B., and Kaltschmidt, C. (2001) J. Biol. Chem., 276, 11821–11829.
Kaltschmidt, C., Kaltschmidt, B., and Baeuerle, P. A. (1995) Proc. Natl. Acad. Sci. USA, 92, 9618–9622.
Burr, P. B., and Morris, B. J. (2002) Exp. Brain Res., 147, 273–279.
Meberg, P. J., Kinney, W. R., Valcourt, E. G., and Routtenberg, A. (1996) Brain Res. Mol. Brain Res., 38, 179–190.
Cruise, L., Ho, L. K., Veitch, K., Fuller, G., and Morris, B. J. (2000) Neuroreport, 11, 395–398.
Koh, S. H., Chang, D. I., Kim, H. T., Kim, J., Kim, M. H., Kim, K. S., Bae, I., Kim, H., Kim, D. W., and Kim, S. H. (2005) Toxicology, 214, 131–139.
Clemens, J. A., Stephenson, D. T., Yin, T., Smalstig, E. B., Panetta, J. A., and Little, S. P. (1998) Stroke, 29, 677–682.
Matsuoka, Y., Kitamura, Y., Okazaki, M., Terai, K., and Taniguchi, T. (1999) Exp. Brain Res., 124, 215–222.
Wang, Z., Kang, J. S., Li, Y., Yuan, Z. X., Liu, S. S., and Sun, L. K. (2006) Toxicol. Appl. Pharmacol., 214, 263–269.
Yu, Z., Zhou, D., Bruce-Keller, A. J., Kindy, M. S., and Mattson, M. P. (1999) J. Neurosci., 19, 8856–8865.
Golden, W. C., and Martin, L. J. (2006) Neuroscience, 137, 133–144.
Ouyang, Y. B., and Giffard, R. G. (2004) Cell Calcium, 36, 303–311.
Yoon, H., Oh, Y. T., Lee, J. Y., Choi, J. H., Lee, J. H., Baik, H. H., Kim, S. S., Choe, W., Yoon, K. S., Ha, J., and Kang, I. (2008) Biochem. Biophys. Res. Commun., 371, 495–500.
Lowe, S. W., Cepero, E., and Evan, G. (2004) Nature, 432, 307–315.
Tanaka, H., Grooms, S. Y., Bennett, M. V., and Zukin, R. S. (2000) Brain Res., 886, 190–207.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2010, Vol. 75, No. 1, pp. 125–135.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Li, SY., Sun, WG., Jia, YH. et al. Calcium signal-initiated early activation of NF-κB in neurons is a neuroprotective event in response to kainic acid-induced excitotoxicity. Biochemistry Moscow 75, 101–110 (2010). https://doi.org/10.1134/S000629791001013X
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S000629791001013X